| Financial toxicity of informal caregivers of colorectal cancer patients: A cross-sectional study M Zhang, X Wang, M Shao, T Li, S Guo, Y Yang, L Yu, M Bin, D Li, H Zhou, ... European Journal of Oncology Nursing 69, 102519, 2024 | 1 | 2024 |
| Induced alternative splicing an opportunity to study PCSK9 protein isoforms at physiologically relevant concentrations JM Cale, KA Ham, D Li, CS McIntosh, GF Watts, SD Wilton, MT Aung-Htut Scientific reports 13 (1), 19725, 2023 | | 2023 |
| Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents J Chen, X Guo, D Li, H Tang, J Gao, W Yu, X Zhu, Z Sun, Z Huang, ... Metallomics 15 (6), mfad035, 2023 | 4 | 2023 |
| Antisense oligomers and methods for treating parkin-related pathologies S Wilton, M Aung-Htut, D Li US Patent App. 17/795,828, 2023 | | 2023 |
| β-cyclodextrin based nano gene delivery using pharmaceutical applications to treat Wolfram syndrome PC Quintas, H Al-Salami, A Pfaff, D Li, S Koks Therapeutic delivery 13 (9), 449-462, 2022 | 4 | 2022 |
| Targeted molecular therapeutics for Parkinson's Disease: A role for antisense oligonucleotides? D Li, FL Mastaglia, WY Yau, S Chen, SD Wilton, PA Akkari Movement Disorders 37 (11), 2184-2190, 2022 | 3 | 2022 |
| Polyglutamine ataxias: our current molecular understanding and what the future holds for antisense therapies CS McIntosh, D Li, SD Wilton, MT Aung-Htut Biomedicines 9 (11), 1499, 2021 | 10 | 2021 |
| Pyrimidine biosynthetic enzyme CAD: its function, regulation, and diagnostic potential G Li, D Li, T Wang, S He International Journal of Molecular Sciences 22 (19), 10253, 2021 | 40 | 2021 |
| Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies D Li, CS McIntosh, FL Mastaglia, SD Wilton, MT Aung-Htut Translational neurodegeneration 10 (1), 16, 2021 | 55 | 2021 |
| Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies. Biomedicines 2021, 9, 1499 CS McIntosh, D Li, SD Wilton, MT Aung-Htut s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| Morpholino oligomer-induced dystrophin isoforms to map the functional domains in the dystrophin protein D Li, AM Adams, RD Johnsen, S Fletcher, SD Wilton Molecular Therapy-Nucleic Acids 22, 263-272, 2020 | 11 | 2020 |
| Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era D Li, FL Mastaglia, S Fletcher, SD Wilton Medicinal Research Reviews 40 (6), 2650-2681, 2020 | 40 | 2020 |
| A splice intervention therapy for autosomal recessive juvenile Parkinson’s disease arising from Parkin mutations D Li, MT Aung-Htut, KA Ham, S Fletcher, SD Wilton International Journal of Molecular Sciences 21 (19), 7282, 2020 | 15 | 2020 |
| Antisense oligonucleotide-mediated exon skipping strategies as the treatment for rare diseases D Li Murdoch University, 2020 | | 2020 |
| Precision medicine through antisense oligonucleotide-mediated exon skipping D Li, FL Mastaglia, S Fletcher, SD Wilton Trends in Pharmacological Sciences 39 (11), 982-994, 2018 | 64 | 2018 |
| Small chemical modulation of induced alternative splicing D Li, K Greer, K West, A Addams, S Fletcher, S Wilton Journal of Gene Medicine 20 (1), 2018 | | 2018 |
| A community-based study of risk factors for probable rapid eye movement sleep behavior disorder JF Ma, Y Qiao, X Gao, L Liang, XL Liu, DH Li, HD Tang, SD Chen Sleep medicine 30, 71-76, 2017 | 51 | 2017 |
| Mutation Analysis of HTRA2 Gene in Chinese Familial Essential Tremor and Familial Parkinson’s Disease YC He, P Huang, QQ Li, Q Sun, DH Li, T Wang, JY Shen, JJ Du, SS Cui, ... Parkinson’s disease 2017 (1), 3217474, 2017 | 15 | 2017 |
| Mutation analysis of CHCHD2 gene in Chinese Han familial essential tremor patients and familial Parkinson's disease patients C Gao, YM Chen, Q Sun, YC He, P Huang, T Wang, DH Li, L Liang, J Liu, ... Neurobiology of Aging 49, 218. e9-218. e11, 2017 | 9 | 2017 |
| Methylation status of DJ-1 in leukocyte DNA of Parkinson’s disease patients Y Tan, L Wu, D Li, X Liu, J Ding, S Chen Translational Neurodegeneration 5, 1-7, 2016 | 17 | 2016 |
Steve WiltonFoundation Chair in Molecular Therapies, Murdoch University在 ccg.murdoch.edu.au 的电子邮件经过验证
